Executive/Major Shareholder Securities Ownership Report Filed
-
The report is in template form; no actual holdings or changes are disclosed
-
No specific information such as new acquisitions, disposals, or shareholder return policies that could affect stock price
-
Routine periodic filing for regulatory compliance; no financial significance
KOSPI Filing Information
-
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
-
Company: MYUNGMOON PHARM (017180)
-
Submission: Im Gi-seop
-
Receipt: 02-03-2026